Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increased drug discovery and development
3.2.1.2 Advancements in cell-based assays
3.2.1.3 Increasing stem cell research
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced assays and instruments
3.2.2.2 Technical complexity requiring expertise
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.2.1 Assay kits
5.2.1.1 Tetrazolium reduction assay kits
5.2.1.1.1 MTT assays
5.2.1.1.2 MTS assays
5.2.1.1.3 XTT assays
5.2.1.1.4 Other tetrazolium reduction assay kits
5.2.1.2 Resazurin cell viability assay kits
5.2.1.3 Calcein-AM cell viability assay kits
5.2.1.4 Other assay kits
5.2.2 Reagents
5.2.3 Microplates
5.3 Instruments
5.3.1 Spectrophotometers
5.3.2 Flow cytometers
5.3.3 Automated cell counters
5.3.4 Microscopy
5.3.5 Cell imaging & analysis systems
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Stem cell research
6.3 Drug discovery & development
6.4 Basic research
6.5 Clinical & diagnostic applications
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Biopharmaceutical & pharmaceutical companies
7.3 CROs & CMOs
7.4 Academic & research institutes
7.5 Diagnostic laboratories
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abcam plc
9.2 Abnova Corporation
9.3 Becton, Dickinson and Company
9.4 Bio-Rad Laboratories, Inc.
9.5 BioTek Instruments, Inc. (Agilent Technologies, Inc.)
9.6 Biotium, Inc.
9.7 Canvax Biotech S.L.
9.8 Creative Bioarray, Inc.
9.9 Danaher Corporation
9.10 Geno Technology, Inc.
9.11 GE Healthcare Technologies, Inc.
9.12 Merck KGaA
9.13 PerkinElmer, Inc.
9.14 Promega Corporation
9.15 Thermo Fisher Scientific Inc.
